Pages that link to "Q46453281"
Jump to navigation
Jump to search
The following pages link to Incidence of second malignancies among patients treated with proton versus photon radiation (Q46453281):
Displaying 50 items.
- Protons, Photons, and the Prostate - Is There Emerging Evidence in the Ongoing Discussion on Particle Therapy for the Treatment of Prostate Cancer? (Q26767399) (← links)
- Secondary Malignancy Risk Following Proton Radiation Therapy (Q26774492) (← links)
- A critical appraisal of the clinical utility of proton therapy in oncology (Q26775826) (← links)
- The Impact of Neutrons in Clinical Proton Therapy (Q26777844) (← links)
- Concepts and challenges in cancer risk prediction for the space radiation environment (Q26800463) (← links)
- Proton radiobiology (Q27025061) (← links)
- Proton therapy for early stage prostate cancer: is there a case? (Q28072657) (← links)
- Therapeutic radiation and the potential risk of second malignancies. (Q30251822) (← links)
- Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada? (Q30428790) (← links)
- Analysis of patient outcomes following proton radiation therapy for retinoblastoma. (Q33782262) (← links)
- New challenges in high-energy particle radiobiology (Q33782346) (← links)
- Promise and pitfalls of heavy-particle therapy (Q34124263) (← links)
- Cardiac avoidance in breast radiotherapy: many choices for a worthwhile objective. (Q34297359) (← links)
- Proton therapy in adjuvant treatment of gastric cancer: planning comparison with advanced x-ray therapy and feasibility report (Q34418908) (← links)
- Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma (Q34484192) (← links)
- Lifetime increased cancer risk in mice following exposure to clinical proton beam-generated neutrons. (Q34984131) (← links)
- A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study (Q34984155) (← links)
- Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute (Q36493816) (← links)
- Proton therapy in the management of non-Hodgkin lymphoma. (Q36518955) (← links)
- Comparative Risk Predictions of Second Cancers After Carbon-Ion Therapy Versus Proton Therapy (Q36833350) (← links)
- Proton beam therapy for pediatric malignancies: a retrospective observational multicenter study in Japan (Q36903278) (← links)
- Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer (Q37149858) (← links)
- Proton therapy for Hodgkin lymphoma (Q38212937) (← links)
- Proton therapy for the treatment of children with CNS malignancies. (Q38233175) (← links)
- The incidence of second brain tumors related to cranial irradiation (Q38284474) (← links)
- Clinical equipoise: Protons and the child with craniopharyngioma (Q38285311) (← links)
- Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience (Q38339108) (← links)
- Defining the role of proton therapy in the optimal management of paediatric patients in Australia and New Zealand (Q38588047) (← links)
- Proton therapy - Present and future (Q38786895) (← links)
- Proton therapy for paediatric CNS tumours - improving treatment-related outcomes. (Q38838663) (← links)
- Sperm preservation and neutron contamination following proton therapy for prostate cancer study. (Q38841590) (← links)
- Optimal Therapy for Early-Stage Hodgkin's Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy (Q39213429) (← links)
- Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors (Q39341353) (← links)
- Proton Therapy for Pediatric Hodgkin Lymphoma (Q39791791) (← links)
- Proton therapy for pediatric and adolescent esthesioneuroblastoma (Q41144000) (← links)
- Range modulation in proton therapy planning: a simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams (Q41895634) (← links)
- Comparative study of the effects of different radiation qualities on normal human breast cells (Q41904503) (← links)
- Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts. (Q42697014) (← links)
- Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop. (Q45212989) (← links)
- Empowering Intensity Modulated Proton Therapy Through Physics and Technology: An Overview (Q46126509) (← links)
- Biological effects of proton radiation: an update (Q46517431) (← links)
- Radiotherapy in testicular germ cell tumours - a literature review. (Q47120992) (← links)
- Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma. (Q47639244) (← links)
- Neutrons in active proton therapy: Parameterization of dose and dose equivalent. (Q47714875) (← links)
- Proton therapy for pediatric cancer: are we ready for prime time? (Q48068097) (← links)
- Underutilization of proton therapy in the treatment of pediatric central nervous system tumors: an analysis of the National Cancer Database. (Q48350255) (← links)
- Treatment tolerance of particle therapy in pediatric patients (Q50591365) (← links)
- Radiation Therapy against Pediatric Malignant Central Nervous System Tumors : Embryonal Tumors and Proton Beam Therapy. (Q55325381) (← links)
- Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry (Q57174479) (← links)
- Radiotherapy Advances in Pediatric Neuro-Oncology (Q58612655) (← links)